We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · March 04, 2021

Fecal Microbiota Transplant Overcomes Resistance to Anti–PD-1 Therapy in Melanoma Patients

Science (New York, N.Y.)


Additional Info

Disclosure statements are available on the authors' profiles:

Science (New York, N.Y.)
Fecal Microbiota Transplant Overcomes Resistance to Anti-PD-1 Therapy in Melanoma Patients
Science 2021 Feb 05;371(6529)595-602, D Davar, AK Dzutsev, JA McCulloch, RR Rodrigues, JM Chauvin, RM Morrison, RN Deblasio, C Menna, Q Ding, O Pagliano, B Zidi, S Zhang, JH Badger, M Vetizou, AM Cole, MR Fernandes, S Prescott, RGF Costa, AK Balaji, A Morgun, I Vujkovic-Cvijin, H Wang, AA Borhani, MB Schwartz, HM Dubner, SJ Ernst, A Rose, YG Najjar, Y Belkaid, JM Kirkwood, G Trinchieri, HM Zarour

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading